Thyroid carcinomas involving follicular and parafollicular C cells: Seventeen cases with characterization of RET oncogenic activation

Thyroid

Volumn 14, Issue 10, 2004, Pages 842-847

  Vantyghem, M C ^a   Pigny, P ^a   Leteurtre, E ^a   Leclerc, L ^a   Bauters, C ^a   Douillard, C ^a   D'Herbomez, M ^a   Carnaille, B ^a   Proye, C ^a   Wemeau, J L ^a   Lecomte Houcke, M ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RET;

ADULT; AGED; ARTICLE; CARCINOGENICITY; CELL HYPERPLASIA; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENETIC TRAIT; GENOTYPE; GOITER; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; OVARY FOLLICLE CELL; PHENOTYPE; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY;

ADULT; AGED; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; HUMANS; HYPERPLASIA; MIDDLE AGED; MUTATION; ONCOGENE PROTEINS; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-RET; PROTO-ONCOGENES; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 8444230064     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2004.14.842     Document Type: Article

References (50)

1. LiVolsi VA 1990 Clarification of thyroid tumors. In: Surgical Pathology of the Thyroid. W.B Saunders Company, Philadelphia, pp. 232-233.
2. Murray D 1991 The thyroid gland. In: Kovacs CS, Asa S (eds) Functional Endocrine Pathology. Blackwell Scientific, Boston, pp 293-374.
3. Matias-Guiu X 1999 Mixed medullary and follicular carcinoma of the thyroid: On the search for its histogenesis. Am J Pathol 155:1413-1418.
4. Volante M, Papotti M, Roth J, Saremaslani P, Speel EJ, Lloyd RV, Carney JA, Heitz PU, Bussolati G, Komminoth P 1999 Mixed medullary-follicular thyroid carcinoma: Molecular evidence for a dual origin of tumor components. Am J Pathol 155:1499-1509.
5. Pfalz M, Hedinger CE, Muhlethaler JP 1983 Mixed medullary and follicular carcinoma of the thyroid. Virchows Arch A Pathol Anat Histopathol 400:53-59.
6. Hedinger C, Williams E, Sobin L 1988 Histologic typing of thyroid tumours. In: World Health Organization International Histologic Classification of Tumors, 2nd ed. Springer-Verlag, Berlin, pp 23-24.
7. Michal M, Curik R, Macak RJ, Ludvikova M, Dedic K 1993 Mixed medullary-follicular and medullary-papillary carcinoma of the thyroid: One or two entities. Zentralblatt Pathologishe 139:333-335.
8. Macak J, Vaverkova H, Dushova M, Perglerova I 1997 Medullary and mixed medullary-papillary carcinoma of the thyroid gland. Pathologica 89:317-322.
9. Tanaka T, Yoshimi N, Kanai N, Mori H, Nagai K, Fujii A, Sakata S, Tokimitsu N 1989 Simultaneous occurrence of medullary and follicular carcinoma in the same thyroid lobe. Hum Pathol 20:83-86.
10. Oishi S, Sasaki M, Sato T, Isogai M 1995 Coexistence of MEN 2A and papillary thyroid carcinoma and a recurrent pheochromocytoma 23 years after surgery: Report of a case and a review of the Japanese literature. Jap J Clin Oncol 25:153-158.
11. Pastolero GC, Coire CI, Asa SL 1996 Concurrent medullary and papillary carcinomas of thyroid with lymph node metastases: A collision phenomenon. Am J Surg Pathol 20:245-250.
12. Henry J, Denizot A, Puccini M, Niccoli P, Conte-Devolx B, de Micco C 1996 Early diagnosis of sporadic medullary thyroid concers of the thyroid: Value of systematic assay of calcitonin. Presse Med 25:1583-1588.
13. Wolfe HJ, Melvin KE, Cervi-Skinner SJ, Saadi AA, Juliar JF, Jackson CE, Tashjian AH Jr 1973 C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med 289: 437-441.
14. Guyétant S, Saint-André JP 2000 Hyperplasie des cellules C et microcarcinomes médullaires de la thyroide. Ann Pathol 20(Suppl):S39-S44.
15. Fluge O, Haugen DR, Akslen LA, Marstad A, Santoro M, Fusco A, Varhaug JE, Lillehaug JR 2001 Expression and alternative splicing of c-RET RNA in papillary thyroid carcinomas. Oncogene 20:885-892.
16. Komminoth P 1997 The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clinical implications. Virchows Arch 431:1-9.
17. Eng C 1999 RET proto-oncogene in the development of human cancer. J Clin Oncol 17:380-393.
18. Reynolds L, Jones K, Winton DJ, Cranston A, Houghton C, Howard L, Ponder BA, Smith DP 2001 C-cell and thyroid epithelial tumors and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET. Oncogene 20:3986-3994.
19. Sugg SL, Ezzat S, Rosen I, Freeman J, Asa SL 1998 Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia. J Clin Endocrinol Metab 83:4116-4122.
20. Learoyd DI, Messina M, Zedenius J, Guinea AI, Delbridge LW, Robinson BG 1998 RET/PTC and RET tyrosine kinase expression in adult papillary carcinomas. J Clin Endocrinol Metab 83:3631-3635.
21. Eng C 2000 Familial papillary thyroid cancer - Many syndromes, too many genes. J Clin Endocrinol Metab 85:1755-1756.
22. Fugazzola L, Cerutti N, Mannavola D, Ghilardi G, Alberti L, Romoli R, Beck-Peccoz P 2002 Multigenerational familial medullary thyroid cancer (FMTC): Evidence for FMTC phenocopies and association with papillary thyroid cancer. Clin Endocrinol 56:53-63.
23. Guyetant S, Wion-Barbot N, Rousselet MC, Franc B, Bigorgne JC, Saint-Andre JP 1994 C-cell hyperplasia associated with chronic lymphocytic thyroiditis: A retrospective quantitative study of 112 cases. Hum Pathol 25:514-521.
24. Barbot N, Calmettes C, Schuffenecker I, Saint-André JP, Franc B, Rohmer V, Jallet P, Bigorgne JC 1994 Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: Comparison with genetic screening in hereditary medullary thyroid carcinoma. J Clin Endocrinol Metab 78:114-120.
25. Wright DK, Mannos MM 1990 Sample preparation from paraffin-embedded tissues. In: Sninsky JJ, White TJ (eds) PCR Protocols: A Guide to Methods and Applications. Academic Press, New York, pp. 153-158.
26. Schuffenecker I, Billaud M, Calender A, Chambe B, Ginet N, Calmettes C, Modigliani E, Lenoir GM 1994 RET proto-oncogene mutations in French MEN 2A and FMTC families. Hum Mol Genet 3:1939-1943.
27. Ceccherini I, Hofstra RM, Luo Y, Stulp RP, Barone V, Stelwagen T, Bocciardi R, Nijveen H, Bolino A, Seri M 1994 DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the RET proto-oncogene. Oncogene 9:3025-3029.
28. Pigny P, Bauters C, Wemeau JL, Houcke ML, Crepin M, Caron P, Giraud S, Calender A, Buisine MP, Kerckaert JP, Porchet N 1999 A novel 9bp duplication in RET exon 8 in FMTC. J Clin Endocrinol Metab 84:1700-1704.
29. Wang C, Crapo LM 1997 The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 26:189-218.
30. Schlesinger MJ, Gargill SL, Saxe IH 1938 Studies in nodular goiter. I. Incidence of thyroid nodules in routine necropsies in a nongoitrous region. JAMA 110:1638-1641.
31. Mortensen JD, Woolner LB, Bennett WA 1955 Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 15:1270-1276.
32. Bondeson L, Lljungberg O 1981 Occult thyroid carcinomas at autopsy in Malmo, Sweden. Cancer 47:319-323.
33. Schindler AM 1982 Occult papillary thyroid cancer. Schweiz Med Wochenschr 112:339-344.
34. Autelitano F, Spagnoli LG, Santeusanio G, Villashi S, Autelitano M 1990 Occult thyroid carcinoma of the thyroid gland: An epidemiological study of autopsy material. Ann Ital Chir 61:141-146.
35. Neuhold N, Kaiser H, Kaserer K 2001 Latent carcinoma of the thyroid in Austria: A systematic autopsy study. Endocr Pathol 12:23-31.
36. Mitselou A, Vougiouklakis T, Peschos D, Dallas P, Agnantis NJ 2002 Occult thyroid carcinoma. A study of 160 autopsy cases. The first report for the region of Epirus-Greece. Anticancer Res 22:427-432.
37. Harach HR, Franssila KO, Wasenius VM 1985 Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 56:531-538.
38. Jacobs JK, Aland JW, Ballinger JF 1983 Total thyroidectomy. A review of 213 patients. Ann Surg 197:542-549.
39. Park SH, Suh EH, Chi JG 1988 A histopathological study on 1,095 surgically resected thyroid specimens. Jpn J Clin Oncol 18:297-302.
40. Pelizzo MR, Piotto A, Rubello D, Casara D, Fassina A, Busnardo B 1990 High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori 76:255-257.
41. Yamashita H, Noguchi S, Watanabe S, Uchino S, Kawamoto H, Toda M, Murakami N, Nakayama I, Yamashita H 1997 Thyroid cancer associated with adenomatous goiter: an analysis of the incidence and clinical factors. Surg Today 27:495-499.
42. Fink A, Tomlinson G, Freeman JL, Rosen IB, Asa SL 1996 Occult micropapillary carcinoma associated with begnin follicular thyroid disease and unrelated thyroid neoplasms. Mod Pathol 9:816-820.
43. Prades JM, Dumollard JM, Timoshenko A, Chelikh L, Michel F, Estour B, Martin C 2002 Multinodular goiter: Surgical management and histopathological findings. Eur Arch Otorhinolaryngol 250:217-218.
44. Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, Lasso-Oria C, Ballestin-Carcavilla C 1993 Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer 71:4022-4029.
45. Gibson WGH, Peng TC, Croker BP 1982 Age associated C-cell hyperplasia in the human thyroid. Am J Pathol 106:388-393.
46. Guyetant S, Rousselet MC, Durigon M, Chappard D, Franc B, Guerin O, Saint-Andre JP 1997 Sex-related C cell hyperplasia in the normal human thyroid: A quantitative autopsy study. J Clin Endocrinol Metab 82:42-47.
47. LiVolsi VA, Feind CR, Lo Gerfo P, Tashjian AH 1973 Demonstration by immunoperoxydase staining of hyperplasia of parafollicular cells in the thyroid gland in hyperparathyroidism carcinoma. J Clin Endocrinol Metab 37:550-559.
48. Scopsi L, Di Palma S, Ferrari C, Holst JJ, Rehfeld JF, Rilke F 1991 C-cell hyperplasia accompanying thyroid diseases other than medullary carcinoma: An immunocytochemical study by means of antibodies to calcitonin and somatostatin. Modern Pathol 4:297-304.
49. Erdogan MF, Gullu S, Baskal N, Uysal AR, Kamel N, Erdogan G 1997 Omeprazole: calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma. J Clin Endocrinol Metabol 82:897-899.
50. Gimm O, Greco A, Hoang-vu C, Dralle H, Pierotti MA, Eng C 1999 Mutation analysis reveals novel sequence variants in NTRK1 in sporadic medullary carcinoma carcinoma. J Clin Endocrinol Metab 84:2784-2787.